Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,78 USD | -0,59% | +0,46% | -22,29% |
Omzet 2024 * | 126 mln. 118 mln. | Omzet 2025 * | 179 mln. 168 mln. | Marktkapitalisatie | 2,95 mld. 2,76 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -313 mln. -293 mln. | Nettowinst (verlies) 2025 * | -304 mln. -284 mln. | EV/omzet 2024 * | 20 x |
Nettoliquiditeiten 2024 * | 426 mln. 399 mln. | Nettoliquiditeiten 2025 * | 313 mln. 293 mln. | EV/omzet 2025 * | 14,7 x |
K/w-verhouding 2024 * |
-8,66
x | K/w-verhouding 2025 * |
-9,26
x | Werknemers | 525 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,51% |
Recentste transcriptie over Arrowhead Pharmaceuticals, Inc.
1 dag | -0,59% | ||
1 week | +0,46% | ||
Lopende maand | -16,85% | ||
1 maand | -12,61% | ||
3 maanden | -30,65% | ||
6 maanden | -3,69% | ||
Lopend jaar | -22,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-12-07 | |
Director of Finance/CFO | 57 | 01-01-09 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 23-11-10 |
Michael Perry
BRD | Director/Board Member | 64 | 19-12-11 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 01-09-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.40% | 0 M€ | 0,00% | - | |
0.35% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 23,78 | -0,59% | 828 397 |
22-04-24 | 23,92 | +7,12% | 1 080 438 |
19-04-24 | 22,33 | -1,24% | 965 833 |
18-04-24 | 22,61 | +0,36% | 1 300 210 |
17-04-24 | 22,53 | -4,82% | 1 149 585 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-22,29% | 2,95 mld. | |
-0,49% | 105 mld. | |
+3,31% | 97,5 mld. | |
+2,91% | 22,19 mld. | |
-16,16% | 21,33 mld. | |
-7,24% | 18,68 mld. | |
-41,41% | 16,6 mld. | |
-22,87% | 14,52 mld. | |
+6,32% | 14,09 mld. | |
+21,46% | 10,99 mld. |